Novel role of the lncRNA EPR as oncosuppressor in intestinal cancer.
Naomi Shim, Maira Rossi, Monica M Nicolau, Jesus R Barajas, Ettore Zapparoli, Paola Briata, Prem Puri, Roberto Gherzi, Luca Caputo
The paper identifies EPR as an oncosuppressor in intestinal cancer, showing its role in goblet cell development and its potential as a prognostic marker and therapeutic target.
bioRxiv · May 1, 2026 · PreprintCancer Biology